1. Home
  2. LSTA vs PSHG Comparison

LSTA vs PSHG Comparison

Compare LSTA & PSHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • PSHG
  • Stock Information
  • Founded
  • LSTA 1980
  • PSHG 2010
  • Country
  • LSTA United States
  • PSHG Greece
  • Employees
  • LSTA N/A
  • PSHG N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • PSHG Marine Transportation
  • Sector
  • LSTA Health Care
  • PSHG Consumer Discretionary
  • Exchange
  • LSTA Nasdaq
  • PSHG Nasdaq
  • Market Cap
  • LSTA 24.2M
  • PSHG 24.2M
  • IPO Year
  • LSTA N/A
  • PSHG N/A
  • Fundamental
  • Price
  • LSTA $2.85
  • PSHG $1.94
  • Analyst Decision
  • LSTA Strong Buy
  • PSHG Strong Buy
  • Analyst Count
  • LSTA 1
  • PSHG 1
  • Target Price
  • LSTA $15.00
  • PSHG $6.50
  • AVG Volume (30 Days)
  • LSTA 15.2K
  • PSHG 71.0K
  • Earning Date
  • LSTA 11-12-2024
  • PSHG 11-07-2024
  • Dividend Yield
  • LSTA N/A
  • PSHG N/A
  • EPS Growth
  • LSTA N/A
  • PSHG N/A
  • EPS
  • LSTA N/A
  • PSHG 1.51
  • Revenue
  • LSTA N/A
  • PSHG $89,608,000.00
  • Revenue This Year
  • LSTA N/A
  • PSHG N/A
  • Revenue Next Year
  • LSTA N/A
  • PSHG $2.66
  • P/E Ratio
  • LSTA N/A
  • PSHG $1.29
  • Revenue Growth
  • LSTA N/A
  • PSHG N/A
  • 52 Week Low
  • LSTA $2.05
  • PSHG $1.70
  • 52 Week High
  • LSTA $3.83
  • PSHG $2.58
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 46.05
  • PSHG 45.55
  • Support Level
  • LSTA $2.75
  • PSHG $1.95
  • Resistance Level
  • LSTA $2.94
  • PSHG $2.04
  • Average True Range (ATR)
  • LSTA 0.21
  • PSHG 0.08
  • MACD
  • LSTA -0.01
  • PSHG -0.01
  • Stochastic Oscillator
  • LSTA 23.08
  • PSHG 33.87

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

About PSHG Performance Shipping Inc.

Performance Shipping Inc is a provider of shipping transportation services through its ownership of tanker vessels. The company's vessels are employed on time charters with liner companies carrying containerized cargo along various shipping routes. It owns and operates eight Aframax tanker vessels.

Share on Social Networks: